MINASTRIN Drug Patent Profile
✉ Email this page to a colleague
When do Minastrin patents expire, and when can generic versions of Minastrin launch?
Minastrin is a drug marketed by Apil and is included in one NDA.
The generic ingredient in MINASTRIN is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MINASTRIN?
- What are the global sales for MINASTRIN?
- What is Average Wholesale Price for MINASTRIN?
Summary for MINASTRIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for MINASTRIN |
| DailyMed Link: | MINASTRIN at DailyMed |
US Patents and Regulatory Information for MINASTRIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apil | MINASTRIN 24 FE | ethinyl estradiol; norethindrone acetate | TABLET;ORAL | 203667-001 | May 8, 2013 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
